Vaughan Nelson Investment Management, L.P. Organon & Co. Transaction History

Vaughan Nelson Investment Management, L.P.

$10.8 Billion
Q4 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 05, 2023	SELL	$21.42 - $32.08 $72,292 - $108,270	-3,375 Reduced 95.47%	160 $4,000
Q2 2021 Jul 15, 2021	BUY	$28.45 - $38.0 $100,570 - $134,330	3,535 New	3,535 $107,000

Others Institutions Holding OGN

# of Institutions

792

Shares Held

203M

Call Options Held

1.71M

Put Options Held

865K

Black Rock Inc. New York, NY

32.6M
Shares

$507 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

30.2M
Shares

$470 Million
0.01% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.2M
Shares

$174 Million
0.41% of portfolio
Massachusetts Financial Services CO Boston, MA

9.76M
Shares

$152 Million
0.06% of portfolio
State Street Corp Boston, MA

8.98M
Shares

$140 Million
0.01% of portfolio

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan Nelson Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Vaughan Nelson Investment Management, L.P. with notifications on news.

Account